Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PHARMAID.BOthis companyPharmaids Pharmaceuticals Limited	₹30.00	-8.36×	2.06×	3.51×	-8.95×	-231.9%	-16.8%	-55.8%	-42.0%	-24.6%	-15.1%	-9.6%	0.49×	-1.72×	-4.46×	0.46×	0.0%	4	—	1	C-
ISHITADR.BOIshita Drugs and Industries Limited	₹74.90	27.17×	1.83×	1.44×	14.96×	-33.0%	19.6%	4.5%	5.3%	6.7%	4.1%	11.6%	0.01×	-2.12×	11.25×	9.65×	0.0%	4	—	2	C+
KIMIABL.BOKimia Biosciences Ltd.	₹30.08	14.36×	6.02×	0.93×	9.9×	58.3%	24.6%	9.0%	6.5%	41.9%	16.9%	-1.8%	1.96×	2.42×	2.95×	1.04×	0.0%	3	—	2	B-
LASA.NSLasa Supergenerics Limited	₹4.22	-0.83×	0.57×	1.13×	-1.34×	-306.6%	-27.4%	-53.2%	-135.6%	-68.7%	-22.1%	0.0%	0.2×	-0.34×	-34.66×	0.62×	0.0%	2	—	2	C
MAKERSL.BOMakers Laboratories Limited	₹267.10	33.88×	1.09×	0.57×	5.78×	-119.2%	39.1%	7.3%	1.7%	3.2%	5.3%	12.9%	0.08×	0.37×	13.24×	2.56×	0.0%	4	—	2	C+
MEDICO.NSMedico Remedies Limited	₹18.88	20.73×	3.6×	1.32×	12.6×	-8.6%	21.6%	6.8%	6.4%	17.4%	10.7%	-1.3%	0.25×	0.75×	7.71×	1.66×	0.0%	4	—	2	B-
Peer median	—	20.73×	1.83×	1.13×	9.9×	-33.0%	21.6%	6.8%	5.3%	6.7%	5.3%	0.0%	0.2×	0.37×	7.71×	1.66×	0.0%	4	—	2	—